Kaczmarek, Tyler and Danilov organized Advanced NeuroRehabilitation, LLC (ANR) to manage neurorehabilitation technologies developed at TCNL.
In 2013, ANR and MPJ Healthcare formed a joint venture called NeuroHabilitation Corporation to develop and commercialize the PoNS device. NeuroHabilitation signed a Collaborative Research and Development Agreement (CRADA) with the US Department of Defense to develop and manage clinical and regulatory activities for the PoNS device and CN-NINM technologies. Late in the year, Philippe Deschamps was named CEO of NeuroHabilitation Corporation.
Through a reverse merger in 2014, Helius Medical Technologies (Helius) acquired NeuroHabilitation as a wholly owned division. Subsequently, Helius became a publicly traded company on the Canadian Stock Exchange in Toronto (ticker symbol: HSM).